GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 427.5M | 305.4M | 202.6M | 234.7M | 212.2M | 179.3M | 196.2M |
| Gross Profit | 298.2M | 194.4M | 90.0M | -26.8M | -16.6M | 4.0M | 82.8M |
| Profitability | |||||||
| Operating Income | -13.1M | -23.2M | -180.6M | -667.7M | -446.1M | -242.0M | -30.4M |
| EBITDA | — | — | — | — | — | — | — |
| Net Income | -21.0M | -52.3M | -175.8M | -549.0M | -245.4M | -241.3M | -29.7M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 29M | 27M | 24M | 10M | 108M | 0M | 0M |
GeneDx Holdings Corp. Income Statement — FAQ
GeneDx Holdings Corp. (WGS) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WGS's income statement history?
The chart and table above show GeneDx Holdings Corp.'s income statement by year and by quarter, including the growth rate.